AbbVie (ABBV) reported that its 2026 adjusted diluted EPS guidance, including third-quarter acquired IPR&D and milestones expense, is $13.76 to $13.96 per share.
The company recorded $216 million of acquired IPR&D and milestones expense in the third quarter ended September 30, 2026, reducing adjusted diluted EPS guidance by $0.11 per share.
- Q3 2026 acquired IPR&D and milestones expense: $216 million.
- Q3 adjusted diluted EPS guidance including the expense: $3.73 to $3.77.
- Full-year 2026 acquired IPR&D and milestones expense included in guidance: $1.251 billion.
- Previous full-year adjusted diluted EPS guidance excluding the Q3 expense: $13.87 to $14.07.
- AbbVie said its 2026 adjusted diluted EPS guidance excludes acquired IPR&D and milestones expense that may occur after the third quarter because it cannot be reliably forecasted.
$ABBV Insider Trading Activity
$ABBV insiders have traded $ABBV stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by insiders over the last 6 months:
- NICHOLAS DONOGHOE (EVP, CHIEF BUS/STRAT OFFICER) sold 32,710 shares for an estimated $8,177,500
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ABBV Hedge Fund Activity
We have seen 2,102 institutional investors add shares of $ABBV stock to their portfolio, and 1,627 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 47,862,796 shares (+inf%) to their portfolio in Q2 2026, for an estimated $12,044,193,985
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 12,914,230 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,249,736,837
- FRANKLIN RESOURCES INC added 5,373,163 shares (+36.9%) to their portfolio in Q2 2026, for an estimated $1,352,102,737
- DIAMANT ASSET MANAGEMENT, INC. removed 3,654,526 shares (-99.5%) from their portfolio in Q2 2026, for an estimated $919,624,922
- CAPITAL WORLD INVESTORS added 3,337,599 shares (+21.1%) to their portfolio in Q2 2026, for an estimated $839,873,412
- MARSHALL WACE, LLP added 2,989,451 shares (+281757.9%) to their portfolio in Q2 2026, for an estimated $752,265,449
- SG AMERICAS SECURITIES, LLC added 2,849,663 shares (+251.0%) to their portfolio in Q2 2026, for an estimated $717,089,197
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ABBV Congressional Stock Trading
Members of Congress have traded $ABBV stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by members of Congress over the last 6 months:
- REPRESENTATIVE PETE SESSIONS sold up to $50,000 on 09/14.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 05/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
